> 数据图表如何了解医疗器械： 2025年前三季度研发费用率略有下滑2025-12-2医疗器械： 2025年前三季度研发费用率略有下滑 医疗控费政策下，厂商持续推进降本增效，器械板块2025Q1-3研发费用（-2.8%）和研发费用率（-0.3pp）略有下滑。器械公司迈瑞医疗联影医疗乐普医疗鱼跃医疗安图生物华大智造新产业开立医疗楚天科技新华医疗英科医疗万孚生物惠泰医疗大博医疗海尔生物东富龙奕瑞科技三诺生物九安医疗理邦仪器医药生物(申万)医疗器械(申万)数据来源：wind，西南证券整理25Q1-324.312.5研发费用/亿元24Q1-325.913.25.94.43.93.83.73.73.63.23.12.72.62.52.42.42.32.22.22.18661635.64.15.15.53.33.44.63.02.92.72.02.12.22.52.52.81.82.4848168yoy-6.1%-5.1%6.7%9.8%-23.1%-30.8%13.7%8.4%-23.1%8.3%5.5%-2.2%25.8%16.6%8.5%-1.7%-8.0%-19.5%25.9%-14.7%2.1%-2.8%研发费用率25Q1-324Q1-3同比变化9.4%14.1%12.0%6.8%12.6%20.5%10.9%25.1%9.1%4.6%4.2%15.7%13.7%13.3%13.8%6.5%14.7%6.5%20.9%14.3%4.8%9.2%8.8%18.9%11.6%6.7%15.1%29.6%9.6%24.2%11.1%4.0%4.1%12.4%13.3%14.0%12.5%7.1%18.3%8.8%8.5%17.6%4.6%9.5%0.6pp-4.8pp0.4pp0.1pp-2.6pp-9.1pp1.3pp0.9pp-2.0pp0.6pp0.0pp3.3pp0.4pp-0.7pp1.2pp-0.5pp-3.5pp-2.3pp12.4pp-3.3pp0.2pp-0.3pp109西南证券健康医疗
